Drawing for INIBIO

USPTO serial 79263560

INIBIO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
DUBRAY, KATHERINE M
Law office
TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with INIBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kisuk Lee

Kisuk Lee Harness, Dickey & Pierce, PLC7700 Bonhomme Ave, Suite 400St. Louis, MO 63105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for health care, namely, for weight loss; muscle relaxants; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting peripheral nervous system; vaccines; crude medicines, namely, plant extracts for medical, veterinary and pharmaceutical purposes; pharmaceutical preparations for the treatment of cardiovascular disease; biopharmaceuticals for the treatment of cancer; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; biological preparations for medical or veterinary purposes, namely, for regulating blood pressure; biological preparations for medical purposes, namely, for preventing cardiovascular disease; skin care preparations for medical purposes, namely, medicated skin care preparations; transdermal patches for medical treatment for use in regulating blood sugar; medicinal herb extracts; pharmaceutical preparations for the treatment of tumours; medicines for dental purposes; pharmaceutical preparations for skin care; herbal medicines, namely, medicinal herbal preparations; nutraceuticals for use as dietary supplements; nutraceuticals for therapeutic purposes, namely, for treating diabetesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 3, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 14, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 14, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 22, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 30, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 30, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 14, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 14, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 2, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 2, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 2, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 4, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 3, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 3, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 2, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 2, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 2, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 2, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 2, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 20, 2019RFNTREFUSAL PROCESSED BY IB—
Sep 5, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 5, 2019RFRRREFUSAL PROCESSED BY MPU—
Aug 11, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 10, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 3, 2019DOCKASSIGNED TO EXAMINER—
Jul 30, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance